• Mashup Score: 0

    The Endocrine Society recently published an update to their guideline, Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings,1 10 years after the initial publication.2 Much has happened over the past decade in the diabetes arena, including the availability of new classes of medications such as SGLT2 inhibitors, long-acting GLP-1 receptor agonists, and shorter-acting…

    Tweet Tweets with this article
    • Online—Hyperglycaemia management in non-critical care settings: guidelines in focus https://t.co/MQNF3UM79D #hyperglycaemia #diabetes #hospital https://t.co/qpwzlwe8LH

  • Mashup Score: 12

    The Endocrine Society recently published an update to their guideline, Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings,1 10 years after the initial publication.2 Much has happened over the past decade in the diabetes arena, including the availability of new classes of medications such as SGLT2 inhibitors, long-acting GLP-1 receptor agonists, and shorter-acting…

    Tweet Tweets with this article
    • RT @TheLancetEndo: #Hyperglycaemia management in non-critical care settings: #guidelines in focus https://t.co/MQNF3UuvL3 #diabetes #hospit…

  • Mashup Score: 4

    The Endocrine Society recently published an update to their guideline, Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings,1 10 years after the initial publication.2 Much has happened over the past decade in the diabetes arena, including the availability of new classes of medications such as SGLT2 inhibitors, long-acting GLP-1 receptor agonists, and shorter-acting…

    Tweet Tweets with this article
    • #Hyperglycaemia management in non-critical care settings: #guidelines in focus https://t.co/MQNF3UuvL3 #diabetes #hospital https://t.co/woE7w7Ma7Z

  • Mashup Score: 7

    The Endocrine Society recently published an update to their guideline, Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings,1 10 years after the initial publication.2 Much has happened over the past decade in the diabetes arena, including the availability of new classes of medications such as SGLT2 inhibitors, long-acting GLP-1 receptor agonists, and shorter-acting…

    Tweet Tweets with this article
    • Mark E Molitch comments on: #Hyperglycaemia management in non-critical care settings: #guidelines in focus https://t.co/MQNF3UM79D #inpatient #hospital #diabetes #NonCriticalCare https://t.co/sJUSMGTliP

  • Mashup Score: 0

    In 2001, the paradigm for blood glucose control in hospitalised patients was challenged by a single-centre, randomised controlled trial (RCT).1 Conducted in mechanically ventilated surgical intensive care unit (ICU) patients (970 [63%] of 1548 following cardiovascular surgery and 1344 [87%] without a previous diagnosis of diabetes), this trial used intravenous insulin to target euglycaemia (blood…

    Tweet Tweets with this article
    • In the August Issue: Blood #glucose targets in the critically ill: is one size fits all still appropriate? https://t.co/O7L9GSaGw2 #hyperglycaemia #hypoglycaemia #hospital